Timing of surgery – No neoadjuvant therapy
Perform surgery within 1 month of a decision to treat with surgery among those patients who do not receive neoadjuvant therapy.
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. The wording is informed by that contained in the Optimal Care Pathway for people with breast cancer (in draft 2020).
Timing of surgery – No neoadjuvant therapy
Perform surgery within 1 month of a decision to treat with surgery among those patients who do not receive neoadjuvant therapy.
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. The wording is informed by that contained in the Optimal Care Pathway for people with breast cancer (in draft 2020).